Parkinson’s disease research shifts toward proteoform-level resolution with Nautilus Biotechnology’s platform

Find out how proteoform-level proteomics could transform Parkinson’s biomarker research and reshape future clinical trials.

Find out how proteoform-level proteomics could transform Parkinson’s biomarker research and reshape future clinical trials.